A survey of United States rheumatologists concerning effectiveness of disease-modifying antirheumatic drugs and prednisone in the treatment of rheumatoid arthritis
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy
Reference32 articles.
1. The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis results of two metaanalyses
2. Use of short-term efficacy/toxicity tradeoffs to select second-line drugs in rheumatoid arthritis. A metaanalysis of published clinical trials
3. Letters
4. The epidemiology of drug treatment failure in rheumatoid arthritis
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. First-Year Radiographic Progression as a Predictor of Further Progression in Early Arthritis: Results of a Large National French Cohort;Arthritis Care & Research;2013-11-27
2. First-line DMARD choice in early rheumatoid arthritis--do prognostic factors play a role?;Rheumatology;2009-12-11
3. What Factors Relate to Job Satisfaction Among Rheumatologists?;JCR: Journal of Clinical Rheumatology;2008-06
4. Factors That Impact Decision Making Among Rheumatologists in the Initiation of Treatment for Hypertension in Rheumatoid Arthritis;JCR: Journal of Clinical Rheumatology;2007-12
5. Use of tumor necrosis factor inhibitors in rheumatoid arthritis: a national survey of practicing United States rheumatologists;Joint Bone Spine;2006-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3